The Swiss medicines agency Swissmedic on Friday approved the vaccination of children aged five to 11 with the Comirnaty vaccine from Pfizer-Biontech.
“The results of clinical trials show that the vaccine is safe and effective in this age group,” he said in a statement.
The Comirnaty vaccine is given in two doses of ten micrograms three weeks apart.
An ongoing clinical trial on more than 1,500 people “shows that the Covid-19 vaccine offers almost complete protection against serious illnesses caused by the SARS-CoV-2 virus in 5 to 11 year olds,” he said. declared.
“Side effects tended to occur less frequently than in adolescents or adults. They included pain at the injection site and fatigue, or less frequently headache, pain in limbs or fever. “, added the agency.
Vaccinations have so far been limited to children 12 years of age or older.
Switzerland is currently experiencing a strong fifth wave of the virus.
Only Comirnaty and Moderna vaccines are authorized in Switzerland.
The country joins Portugal, Italy, Greece and Spain in Europe to give the green light to the vaccination of children of this age group.
Canada and the United States as well as Israel and Chile have also authorized vaccination of children of the same age.
In France, the vaccination has only been approved for young children at risk of developing serious illness, but the government has said it is considering extending it to all children on a voluntary basis.
This story was posted from an agency feed with no text editing. Only the title has been changed.
Never miss a story! Stay connected and informed with Mint. Download our app now !!